Insider · CIK 0002109760
Jiming Zhou
Files at AIDX (20/20 Biolabs, Inc.). First filing -, latest -.
In brief
Jiming Zhou files SEC Form 4 as COO at AIDX (20/20 Biolabs, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jiming Zhou has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | AIDX 20/20 Biolabs, Inc. | AGrant or award Stock Optionderivative | +150,000 | $0.00 | $0 | 150,000 | Apr 6, 2026 |
Questions about Jiming Zhou
Answered from the filings on this page, as of the latest one.
Is Jiming Zhou buying or selling?
Jiming Zhou has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jiming Zhou's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jiming Zhou has 0.
Where does Jiming Zhou file Form 4?
Jiming Zhou has filed Form 4 at AIDX (20/20 Biolabs, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.